Women's Health
Specialized products for feminine well-being at all stages of life.
- Menstrual cycle supplements
- Menopause products
- Prenatal vitamins
- Supplements for bone health
- Products for hormonal balance
Comprehensive care designed specifically for the needs of women.
Sort by:
91 products
91 products
YASMIN (DROSPIRENONE / ETHINYL ESTRADIOL)
Comparable to: Yasmin
Active substance: Drospirenone / Ethinyl Estradiol
Concentration: 3 mg / 0.03 mg per tablet
Presentation: Box with 21 tablets
Laboratory: BAYER
Origin: Mexico
Yasmin is a combined oral contraceptive medication used to prevent pregnancy. Drospirenone and ethinyl estradiol work together to inhibit ovulation, alter cervical mucus, and modify the endometrium, thereby reducing the likelihood of conception.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Oral contraceptive with antiandrogenic effects antimineralocorticoid and also beneficial for women with fluid retention of hormone and the resulting symptoms and women with acne and seborrhea.
CONTRAINDICATIONS: Do not use oral contraceptives (COCs) in the presence of any of the situations listed below. Must cease immediately the use of prepared if any of them for the first time during his employment:
• Presence or history of thrombotic / thromboembolic arterial or venous (eg, deep vein thrombosis, pulmonary embolism, myocardial infarction) or stroke.
• Presence or history of prodrome of a thrombosis (eg transient ischemic attack, angina pectoris).
• History of migraine with focal neurological symptoms.
• Diabetes mellitus with vascular involvement.
• The presence of a serious risk factor or multiple risk factors for arterial or venous thrombosis may also constitute a contraindication (see Precautions).
• Presence or history of pancreatitis if it is associated with hypertriglyceridemia.
• Presence or history of severe liver disease while the liver function values have not returned to normal.
• severe renal insufficiency or acute renal failure.
• Presence or history of liver tumors (benign or malignant).
• known or suspected neoplasms, influenced by sex steroids (for example, of the genitals or the breasts).
• Undiagnosed vaginal bleeding.
• Pregnancy known or suspected.
• Hypersensitivity to the active substances or any of the excipients.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: YASMIN ® is not indicated during pregnancy. If a woman becomes pregnant while taking YASMIN ®, discontinue administration.
However, epidemiological studies on a large scale have not revealed an increased risk of birth defects in children of mothers who used COCs prior to pregnancy or a teratogenic effect when COCs were taken inadvertently during early pregnancy.
The available data on the use of Yasmin ® during pregnancy are too limited to draw conclusions about the negative effects of Yasmin ® about pregnancy, health of the fetus or the newborn. Not yet available relevant epidemiological data.
Breastfeeding can be affected by the AOC, as they may reduce the amount of milk and alter its composition and therefore should not be recommended in general the use of AOC until the mother has not completely stopped breastfeeding. Small amounts of contraceptive steroids and / or its metabolites can be eliminated by milk.
DOSAGE AND ADMINISTRATION:
How to take Yasmin ®: If taken properly, combined oral contraceptives have a failure rate of about 1% per year. This failure rate may increase if you forget or take the pill incorrectly. Thetablets should be taken in the order indicated on the package every day at about the same time with a little liquid if necessary. It will take one tablet daily for 21 consecutive days. Each package will start back after an interval of 7 days without pills, which usually occurs during a withdrawal bleed. The bleeding usually begin 2-3 days after taking the last tablet and may not have finished where appropriate to start the next pack.
PREMARIN (CONJUGATED ESTROGENS)
Comparable to: Premarin
Active ingredient: Conjugated estrogens
Concentration: 0.625 mg
Presentation: Box with 42 tablets
Manufacturer: Wyeth
Origin: Mexico
Premarin is a hormonal medication indicated for the treatment of symptoms associated with menopause, such as hot flashes, night sweats, and vaginal changes. It can also be used in hormone replacement therapies and in certain gynecological disorders, helping to restore hormonal balance.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PROGYLUTON (ESTRADIOL / NORGESTREL)
Comparable to: Progyluton
Active substance: Estradiol / Norgestrel
Presentation: Box with 21 dragees
Laboratory: Bayer de Mexico
Origin: Mexico
Progyluton is a hormonal medication primarily used to regulate the menstrual cycle and as part of hormone therapies for gynecological disorders. The combination of estradiol and norgestrel acts on the endocrine system, helping to balance female hormone levels.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
Reosvec 35 mg
Comparable to: Actonel
Active ingredient: Risedronate
Concentration: 35 mg per tablet
Presentation: Box with 4 tablets
Laboratory: RAAM
Origin: Mexico
This medication is used for the treatment and prevention of osteoporosis, helping to strengthen bones and reduce the risk of fractures by inhibiting bone resorption.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
PROVERA (MEDROXYPROGESTERONE)
Comparable to: Provera
Active ingredient: Medroxyprogesterone
Concentration: 5 mg
Presentation: Box with 24 tablets
Laboratory: PFIZER
Origin: Mexico
Provera is a hormonal medication indicated for the treatment of various gynecological disorders, such as menstrual cycle irregularities, secondary amenorrhea, dysfunctional uterine bleeding, and as part of hormone therapies. It works by regulating hormonal balance and promoting normal endometrial function.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PREMARIN Vaginal Cream 43 g
Comparable to: Premarin
Active ingredient: Conjugated estrogens
Presentation: Tube with 43 g of vaginal cream
Laboratory: Wyeth
Origin: Mexico
This medication is used for the treatment of vaginal symptoms associated with menopause, such as dryness, itching, and pain during sexual intercourse. Conjugated estrogens help restore the vaginal mucosa and improve tissue lubrication and elasticity.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
Contraindications: Suspected or confirmed pregnancy (see Restrictions of use during pregnancy and lactation).
Undiagnosed abnormal bleeding.
Suspected or confirmed estrogen-dependent neoplasia (eg endometrial cancer, endometrial hyperplasia).
History of active arterial thromboembolic disease (eg stroke, myocardial infarction) or deep thromboembolism (such as deep vein thrombosis, pulmonary embolism).
Dysfunction or active liver disease or chronic.
Known or suspected hypersensitivity to ingredients.
GENERAL PRECAUTIONS: Systemic absorption can occur with the use of vaginal cream with ECE. It must take into account the precautions and warnings associated with the oral treatment of ECE.
Fluid retention: Since estrogen / progestin may cause a degree of fluid retention in patients with conditions that can be influenced by this factor, such as cardiac or renal dysfunction, ensure careful observation when estrogens are prescribed.
In the study of health and osteoporosis, progestin and estrogen (HOPE), the mean increases from baseline in serum triglycerides after one year of treatment with CEE 0.625, 0.45 and 0.3 mg compared with placebo were 34.3,30.2 , 25.1, and 10.7 respectively.
Impaired liver function: Patients with impaired liver function may metabolize poorly estrogen / progestin.
History of cholestatic jaundice: For patients with a history of cholestatic jaundice associated with past use of estrogen or pregnancy, caution should be exercised, and in case of recurrence, medication should be discontinued.
You must select the lowest dose that controls your symptoms and should be discontinued ifsymptoms persist.
Usual dose range: ½ to two grams a day, vaginally, depending on the severity of the condition. Ensure that the discontinuation or reduction of medication takes place at intervals of 3 to 6 months.
Concomitant progestogen: The addition of a progestin during the administration of estrogenreduces the risk of endometrial hyperplasia and carcinoma, which has been associated withlong-term use of unopposed estrogen.
Morphological and biochemical studies of endometrium suggest that you need to manage for 10 to 14 days to provide maximum maturation of the endometrium in order to eliminate anyhyperplastic alteration.
Since progestogens are administered to protect against endometrial hyperplastic changes, patients without a uterus may not need a progestin. Administration should be cyclic (eg, three weeks of treatment and rest) and only for short-term therapy.
Patients should be reevaluated periodically to determine whether treatment of the symptomsis still necessary.
VAGITROL-V 10 OVULES
Comparable to: Vagitrol-V
Active ingredient: Fluocinolone Acetonide, Metronidazole, and Nystatin
Presentation: Box with 10 vaginal ovules
Laboratory: BAYER
Origin: Mexico
This medication is used for the treatment of vaginal infections, helping to relieve symptoms such as discharge, itching, burning, and irritation, according to medical indication.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Related Products
- Choosing a selection results in a full page refresh.
- Opens in a new window.